跳转至内容
Merck
CN

K3628

Kininogen, low molecular weight 来源于人类血浆

≥95% (SDS-PAGE), lyophilized powder

别名:

LMW kininogen

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352200
NACRES:
NA.32
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Kininogen, low molecular weight 来源于人类血浆, ≥95% (SDS-PAGE), lyophilized powder

biological source

human plasma

assay

≥95% (SDS-PAGE)

form

lyophilized powder

mol wt

64000 Da

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

Quality Level

Gene Information

Biochem/physiol Actions

Extracellular cysteine proteinase inhibitor.
LMW kininogen is a major extracellular cysteine proteinase inhibitor. Tissue kallikrein releases bradykinin, a potent bronchoconstrictor and vasoactive agent, from both HMW and LMY kininogen.

Physical form

Lyophilized from a solution in sodium acetate and sodium chloride.

Application

Kininogen, low molecular weight from human plasma has been used to study rMASP-1 (recombinant mannose-binding lectin-associated serine protease 1)-mediated cleavage of LK (low molecular weight kininogen). It has been used as a standard for protein identification in milk-proteomics study.

存储类别

13 - Non Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

高风险级别生物产品--人源产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Delphine Vincent et al.
Frontiers in genetics, 6, 360-360 (2016-01-23)
Milk is a complex fluid whose proteome displays a diverse set of proteins of high abundance such as caseins and medium to low abundance whey proteins such as ß-lactoglobulin, lactoferrin, immunoglobulins, glycoproteins, peptide hormones, and enzymes. A sample preparation method
József Dobó et al.
PloS one, 6(5), e20036-e20036 (2011-06-01)
Bradykinin (BK), generated from high-molecular-weight kininogen (HK) is the major mediator of swelling attacks in hereditary angioedema (HAE), a disease associated with C1-inhibitor deficiency. Plasma kallikrein, activated by factor XIIa, is responsible for most of HK cleavage. However other proteases
Xavier Charest-Morin et al.
Pharmacology research & perspectives, 3(2), e00119-e00119 (2015-06-04)
Tissue kallikrein (KLK-1), a serine protease, initiates the release of bradykinin (BK)-related peptides from low-molecular weight kininogen. KLK-1 and the BK B2 receptor (B2R) mediate beneficial effects on the progression of type 2 diabetes and renal disease, but the precise

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持